Bengt Herweg, MD, FACC

Office Address: Florida Heart Rhythm Institute

Harbourside Medical Tower, Suite 830

5 Tampa General Circle

Tampa FL 33606

Office Phone: (813) 374 2177

Cell phone (813) 420 8287

Fax: (813) 374 2178

E-mail: bherweg@tamabay.rr.com

Education:

1982-1984 University Essen, School of Medicine, West Germany

Premedical Training, “Physicum” August 1984

1984-1988 University Essen, School of Medicine, West Germany

Medical Training, Graduation November 22, 1988

Doctoral Dissertation May 13, 1991 (“cum laude”)

Postdoctoral Training:

11/88-8/90 Elizabeth Hospital, Recklinghausen, West Germany

Internship Internal Medicine

3/91-6/93 Beth Israel Medical Center

Mount Sinai School of Medicine, New York, NY

Resident Internal Medicine

7/93-6/94 Beth Israel Medical Center

Mount Sinai School of Medicine, New York, NY

Chief Resident Internal Medicine

7/94-6/97 Montefiore Medical Center

Albert Einstein College of Medicine, Bronx, NY

Fellowship Cardiology

7/97-6/98 Montefiore Medical Center

Albert Einstein College of Medicine, Bronx, NY

Fellowship Electrophysiology & Device Therapy

Licensure:

1992-2004 New York State License Registration

2002-2003 Florida Teaching Certificate

2003-Present Florida State License

1992- California State License

Board Certification:

1994-2004 Diplomate, American Board of Internal Medicine

1997-2018 Diplomate, Cardiovascular Disease, ABIM

2000-2010 Diplomate, Clinical Cardiac Electrophysiology, ABIM

Academic Appointments:

2/2000 – 7/2002 Instructor in Medicine, College of Physicians and Surgeons, NY

6/2002 – 6/2007 Assistant Professor of Medicine, University of South Florida, Tampa, FL

6/2007 – present Associate Professor of Medicine, University of South Florida, Tampa, FL

Professional Employment and Hospital:

7/1998-6/2000 Post-Doctoral Research Scientist, Department of Pharmacology

Columbia University, College of Physicians and Surgeons, New York, NY

2/2000-7/2002 Junior Attending/Staff Physician, Department of Medicine

Division of Cardiology & Cardiac Electrophysiology

St. Luke’s-Roosevelt Hospital Center, New York, NY

12/2000 – 7/2002 Attending/Staff Physician, Department of Medicine

Valley Hospital, Ridgewood, NJ

2001 – 7/2002 Attending/Staff Physician, Department of Medicine

Bronx Lebanon Hospital, Bronx, NY

2001 – 7/2002 Attending/Staff Physician, Department of Medicine

St. Vincent Hospital, Staten Island, NY

7/2002-6/2008 Director, Electrophysiology & Arrhythmia Services

Division of Cardiology, Department of Medicine

University of South Florida

7/02 - Present Attending/Staff Physician

Tampa General Hospital, Tampa FL

6/2002 – Present Attending/Staff Physician

H. Lee Moffitt Cancer Center and Research Institute, Tampa FL

6/2002 – Present Attending/Staff Physician

James A. Haley Veterans Administration Hospital, Tampa FL

7/2006 – 6/2008 Program Director, Clinical Cardiac Electrophysiology Fellowship

University of South Florida

Membership Professional Societies:

1998 - Current Fellow, American College of Cardiology

1997 - Current Member, American Heart Association

1997 - Current Member, Heart Rhythm Society

1999 - Current Member, Cardiac Electrophysiology Society

Membership Professional Committees:

2001 – Current New Leaders in Cardiology and Cardiac Electrophysiology (NELCEP)

2005 – Current Scientific and Clinical Documents Committee, Heart Rhythm Society

Manuscript Reviewer

(1997-1998) Journal of Cardiovascular Diagnosis and Procedures

(2001-2002) Journal of Cardiovascular Pharmacology

(2003-2008) Pacing and Clinical Electrophysiology

(2005-2008) Journal of Interventional Cardiac Electrophysiology

(2006-2007) Heart Rhythm

(2007-2008) American Journal of Cardiology

(2006-2008) Journal of the American College of Cardiology

Linguistic Skills: English, German, Italian

Funded Research:

1.Site Co-Investigator. Dual hamber and VVI implantable defibrillator (DAVID) trial. St. Jude Medical, Inc., St. Paul, MN.

2.Site Co-Investigator. Multicenter evaluation of the NavistarTM Thermocool® catheter with Stockert generator for the endocardial ablation in patients with typical atrial flutter. Biosense Webster, Inc., Diamond Bar, CA.

3.Principal Investigator. In Vivo Investigation of Thrombogenesis And Lesion Generation Using an Expandable Mesh Electrode Catheter For Left-Sided Ablation in a Canine Model. Sponsored by Bard Electrophysiology, Lowell, MA. $15,000.00 grant. 10 dog experiments completed.

4.Principal Investigator (PI). Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (PAVE). St. Jude Medical, Inc., St. Paul, MN (6/10/2003 to 4/19/2004, $6,100 per patient, 1 patient enrolled).

5.Principal Investigator (PI). Phase I placebo controlled non-randomized crossover study of the safety of intravenous ATPaceTM (adenosine 5’-triphosphosphate) in elderly patients with neuronally-mediated syncope. (3/10/2003-5/20/2003, $3,210/patient, 1 patient enrolled).

6.Principal Investigator (PI). Phase II, placebo controlled, non-randomized study of intravenous ATPaceTM (adenosine 5’-triphosphosphate) for the diagnosis of bradycardic syncope. Duska Scientific Protocol #DS-03-01, USF Account #6173-A673V5 ($2000/patient, trial currently on hold, no enrolments).

7.Co-Investigator. “Gender-related cardiovascular effects of smoking and the value of L-Arginine.” Florida Department of Health, James and Esther King Biomedical Research grant for New Investigator Research. Grant # 04NIR-08, 8/1/04-6/30/07 (total amount granted $294,000, 11 patients enrolled).

8.Principal Investigator (PI). Multisite program to access and review trending information and evaluate correlation to symptoms in patients with heart failure (PARTNERS HF). Medtronic, Inc., Minneapolis, St. Paul, MN (2005-present, goal 15 patients, 8 patients enrolled, $2,250 per patient enrolled).

9.Principal Investigator (PI). Evaluation of the safety and efficacy of the OPTIMIZER™ system with active fixation leads in subjects with heart failure resulting from systolic dysfunction (FIX-HF-5). Impulse Dynamics, Inc., NJ (2006-present, goal 6 patients, control group $8,561.00 per patient, device group $19,658.00/patient, 6 consented, 2 enrolled, 1 in screening).

10.Co-Principal Investigator (Co-PI). Block HF. Efficacy of cardiac re-synchronization therapy in patients requiring permanent pacing for complete AV block. Medtronic, Inc., Minneapolis, St. Paul, MN (2006-present, goal 10 patients, 1 patient enrolled, $7,500 for patients randomized to right ventricular pacing, $19,268 for patients randomized to bi-ventricular pacing)

11.Principal Investigator (PI). Investigation of cryoablation effectiveness in paroxysmal atrial fibrillation (ICE-PAF). Cryocor, Inc., San Diego, CA. Protocol #GL-AF-02, USF Acct #6173-A673AY (goal 4 patients, currently in the approval process, $6,350 for patients randomized to the ablation arm, $5,170 for patient randomized to medical therapy, $12,000 for patients that cross over and completed the study).

Invited Lectures

1.International

1.Electrocardiography of ventricular resynchronization. 9th Didactic Course on Cardiac Pacing. Cardiostim (14th World Congress in Cardiac Electrophysiology and Cardiac Techniques) June 16, 2004, Nice, France

2.Importance of latency and patterns of intraventricular conduction during left ventricular pacing. 11th Didactic Course on Cardiac Pacing. Cardiostim (16th World Congress in Cardiac Electrophysiology and Cardiac Techniques) June 19, 2008, Nice, France

2.National

1.Observations on a hybrid approach to AF ablation. Cryocath Ablating Complex Arrhythmias Seminar. Las Vegas, Nevada, October 11, 2008

2.Ischemia and infarction in bundle branch block. Getting more from the electrocardiogram. American College of Cardiology (57 Annual Scientific Session), Chicago, IL, March 31, 2008.

3.Observations on a hybrid approach to AF ablation. Cryocath AF Ablation Symposium. Las Vegas, Nevada, February 9, 2008

4.Core Curriculum – Efficient diagnosis of paroxysmal supraventricular tachycardia in the electrophysiology laboratory. Heart Rhythm 2007 (28th Annual Scientific Session) Denver, CO, May 10, 2007.

5.How to Manage the Non-Responder to Cardiac Resynchronization Therapy. Intra-Ventricular conduction delays, intra-atrial conduction delays and rhythm perturbations in patients undergoing CRT. American Heart Association (79th Scientific Session), Chicago, IL, November 15, 2006.

6.Core Curriculum - Ventricular Pacing: Where? How? Programming the AV delay: The long and short of it. Heart Rhythm 2006 (27th Annual Scientific Session) Boston, MA, May 18, 2006.

7.Case-Based Tutorial - Using Pacing Maneuvers to Diagnose SVT. Heart Rhythm 2006 (27th Annual Scientific Session) Boston, MA, May 18, 2006.

8.Chairman. Core Curriculum Session 29. Advances in cardiac resynchronization therapy 2005. Heart Rhythm 2005 (26th Annual Scientific Session) New Orleans, Louisiana, May 6, 2005.

3.Regional

1.Non-pharmacologic therapy of atrial fibrillation. Internal Medicine Grand Rounds. Orlando Regional Medical Center, February 27, 2003.

2.Combination therapy for atrial fibrillation: A way out for problem patients? Symposium at Roosevelt Hospital Center, New York, NY, May 4, 2002. Diagnosis and management of cardiac arrhythmias.

3.Who should receive chronic anticoagulation? Risks and benefits. Symposium at Roosevelt Hospital Center, New York, NY, May 12, 2001. Diagnosis and management strategies for atrial fibrillation. An update for the practicing physician.

4.Sudden cardiac death in CHF patients. Incidence and risk factors. Symposium at Roosevelt Hospital Center, New York, NY, May 2000. Diagnosis and management of cardiac arrhythmias: Focus on congestive heart failure.

4.Local

1.Curative therapy for atrial fibrillation. Hyde Park Community Center, Tampa, FL, Novenber 2006

2.Ablation of atrial fibrillation. The USF experience. Florida Arrhythmia group meeting 2005, Charley’s Steak House, Tampa, FL

3.What is atrial fibrillation? Is there an option for cure? Senior Health Series in Sun City Center, Florida March 23, 2005

4.Arrhythmias and sleep disordered breathing. Annual course on sleep disordered breathing. Don Cesar Beach Resort, St. Pete Beach, Florida, September 11, 2004

5.Risk stratification for primary prevention of sudden cardiac death. SCD-HEFT results. The Centre Club, Tampa, Florida, May 10, 2004

6.Pulmonary vein isolation: A curative therapy for atrial fibrillation. Cardiovascular Symposium. Wyndham Westshore Hotel, Tampa Florida, April 12, 2003.

7.Palpitations: Be still my beating heart! Mini Med School Lecture. Tampa Bay Performing Arts Center, March 3, 2003.

8.Atrial fibrillation: Mechanism and rational for non-pharmacologic therapy. Grand Rounds at Tampa General Hospital, University of South Florida, November 7, 2001.

Publications

Original, Peer Reviewed Articles

1.Löhr E, Herweg B, Glocke P. Radiological aspects of arteriosclerosis: Follow-up study of 588 patients in two different groups. Angiology 1993; 44(3):210-216.

2.Herweg B, Dalal P, Nagy B, Schweitzer P. Power spectral analysis of heart period variability of preceding sinus rhythm before initiation of paroxysmal atrial fibrillation. Am J Cardiol 1998; 82:869-874.

3.Herweg B, Fisher JD, Ilercil A, Martinez MR, Gross JN, Kim SG, Ferrick KJ. Cardiac memory after radiofrequency ablation of accessory pathways: The post ablation T-wave does not forget the pre-excited QRS. J Intervent Cardiac Electrophysiol 1999; 3(3):265-274.

4.Herweg B, Toosi B, Fisher JD, Ferrick KJ. Autonomic modulation and atrial fibrillation in the Wolff-Parkinson-White syndrome. Am J Cardiol 2000; 85(10):1256-1259.

5.Herweg B, Chang F, Chandra P, Danillo P, Rosen MR. Cardiac memory in canine atrium. Identification and Implications. Circulation 2001; 103:455-461.

6.Herweg B, Weiner S, Ilercil A, Polosajian L, Ferrick KJ, Fisher JD. Cardiac memory, a surface electrocardiographic clue in the differential diagnosis of ongoing narrow complex tachycardia. Am J Cardiol 2002; 90(4):428-431.

7.Barold SS, Herweg B, Gallardo I. Aquired atrioventricular block: the 2002 ACC/AHA/NASPE guidelines for pacemaker implantation should be revised. Pacing Clin Electrophysiol 2003; 26:531-533.

8.Barold SS, Herweg B, Gallardo I. Underutilization of the DDIR mode in ICD patients. Pacing Clin Electrophysiol 2003; 26:803-804.

9.Herweg B, Kowalski M, Steinberg JS. Termination of persistent atrial fibrillation resistant to cardioversion by a single radiofrequency application. Pacing Clin Electrophysiol 2003;26(6):1420-1423.

10.Barold SS, Herweg B, Gallardo I. Double counting of the ventricular electrogram in biventricular pacemakers and ICDs. Pacing Clin Electrophysiol 2003;26(6):1645-1648.

11.Herweg B, Barold SS. Anodal capture with second-generation biventricular cardioverter-defibrillator. Acta Cardiol 2003;58(5):435-6.

12.Chandra P, Rosen TS, Herweg B, Danilo P, Rosen MR. Left atrial pacing induces memory and is associated with atrial tachyarrhythmias. Cardiovasc Res 2003;60(2):307-314.

13.Herweg B, Ilercil A, Whitaker D, Hamilton L, Khan N, Barold SS. Treatment of sustained left atrial tachycardia by pulmonary vein isolation. Pacing Clin Electrophysiol 2004;27(8):1153-1157.

14.Steinberg JS, Arshad A, Kowalski M, Kukar A, Suma V, Vloka ME, Ehlert FA, Herweg B, Donelly JE, Phillip J, Reed G, Rozanski A. In the aftermath of the World Trade Center attack: Increased incidence of life-threatening arrhythmias in implantable defibrillator patients in the New York community. J Am Coll Cardiol 2004;44:1261-1264.

15.Herweg B, Sichrovsky TC, Polosajian L, Rozenshtein A, Steinberg JS. Hypertension and hypertensive heart disease are associated with increased ostial pulmonary vein diameter. J Cardiovasc Electrophysiol 2005;16(1):2-5.

16.Barold SS, Herweg B. Upper rate response of biventricular pacing devices. J Intervent Card Electrophysiol 2005;12(2):129-36.

17.Herweg B, Sichrovsky TC, Polosajian L, Steinberg JS. Ultrasound-guided left atrial pulmonary vein disconnection for treatment of atrial fibrillation: Anatomic substrate, procedural results and clinical outcome. Am J Cardiol 2005;95(7):871-5.

18.Barold SS, Herweg B, Sweeny MO. Minimizing right ventricular pacing. Am J Cardiol 2005;95(8):966-9.

19.Barold SS, Herweg B, Giudici M. Electrocardiographic follow-up of biventricular pacemakers. Ann Noninvasive Electrocardiol. 2005;10(2):231-55.

20.Barold SS, Herweg B. Right ventricular Outflow Tract Pacing: Not Ready For Prime-Time. J Interv Card Electrophysiol 2005 Jun;13(1):39-46.

21.Barold SS, Herweg B. Phantom Crosstalk. Pacing Clin Electrophysiol. 2005;28(4):334-335.

22.Herweg B, Barold SS. Ventricular asystole during atrial antitachycardia pacing by implanted cardioverter-defibrillator. Pacing Clin Electrophysiol. 2005;28(5):432-3.

23.Barold SS, Herweg B. Pulsus alternans caused by 2:1 left bundle branch block. J Interv Card Electrophysiol. 2005;12(3):221-2.

24.Chandra P, Rosen TS, Herweg B, Danilo P, Rosen MR. The left atrial gradient as a potential predictor of atrial fibrillation. Heart Rhythm 2005;2:404-410.

25.Barold SS, Herweg B. Mysterious loss of synchronization during biventricular pacing. Pacing Clin Electrophysiol. 2005;28;571-572.

26.Herweg B, Whitaker DM, Barold SS. Coexistence of intracardiac atrial flutter and extracardiac fibrillation. J Interv Card Electrophysiol. 2005;13(1):71-2.

27.Barold SS, Herweg B, Curtis AB. The defibrillation safety margin of patients receiving ICDs: A matter of definition. Pacing Clin Electrophysiol. 2005;28(9):881-2.

28.Ilercil A, Barack BS, Malone M, Barold SS, Herweg B. Two-Dimensional, Color Doppler and Contrast Echocardiographic Features of Noncompaction of Left Ventricular Myocardium in a Patient With Ebstein’s Anomaly. Echocardiography 2006;23(5):432-33.

29.Barold SS, Israel CW, Herweg B. Mode switching of dual chamber pacemakers from activation of a blanked flutter search algorithm by a single atrial event. Pacing Clin Electrophysiol. 2005;28(9):917-20.

30.Bangalore S., Petre L, Herweg B, Sichrovsky T, Steinberg JS, Chaudhry F. Cardioversion in patients with left ventricular thrombus is not associated with increased thromboembolic risk. J Am Soc Echocardiogr. 2006;19(4):438-40.

31.Barold SS, Herweg B. Alternating preventricular and postventricular atrial far-field sensing by a dual chamber cardioverter defibrillator. Pacing Clin Electrophysiol. 2005;28(12):1320-1.

32.Herweg B, Ilercil A, Madramootoo C, Krishnan S, Rinde-Hoffman D, Weston M, Curtis AB, Barold SS. Latency during left ventricular pacing from the lateral cardiac veins: A cause of ineffectual biventricular pacing. Pacing Clin Electrophysiol. 2006;29:574-581.

33.Barold SS, Giudici MC, Herweg B, Curtis AB. Diagnostic value of the 12-lead electrocardiogram during conventional and biventricular pacing for cardiac resynchronization. Cardiology Clinics 2006;24:471-490.

34.Barold SS, Herweg B, Curtis AB. Electrocardiographic diagnosis of myocardial infarction and ischemia during cardiac pacing. Cardiology Clinics 2006;24;387-399.

35.Barold SS, Herweg B. Electrocardiographic diagnosis of myocardial infarction during left bundle branch block. Cardiology Clinics 2006;24:377-385.

36.Barold SS, Herweg B, Curtis AB. Electrocardiographic diagnosis of myocardial infarction and ischemia during right ventricular pacing. J Electrocardiol. 2007 Apr;40(2):164-7.

37.Barold SS, Stroobandt RX, Sinnaeve AF, Herweg B. Confusing ICD Terminology; Refractory and Blanking Periods. Pacing Clin Electrophysiol. 2006;29:923-925.

38.Barold SS, Herweg B. ICD discharge triggered by atrial bigeminy. Pacing Clin Electrophysiol. 2006;29:991-995.

39.Herweg B, Johnson N, Postler G, Curtis AB, Barold SS, Ilercil. A. Mechanical esophageal deflection during ablation of atrial fibrillation. Pacing Clin Electrophysiol. 2006;29:957-961.

40.Barold SS, Leonelli F, Herweg B. Hyperkalemia during cardiac pacing. Pacing Clin Electrophysiol. 2007 Jan;30(1):1-3.

41.Barold SS, Leonelli F, Khan N, Cutro R, Herweg B. Pacemaker Tachycardia: Is it Pacemaker-Mediated Tachycardia or Sinus Tachycardia? Pacing Clin Electrophysiol. 2007;30:256–257.

42.Barold SS, Ilercil A, Leonelli F, Herweg B. First-degree atrioventricular block : Clinical manifestations, indications for pacing, pacemaker management & consequences during cardiac resynchronization. J Interv Card Electrophysiol. 2006;17(2):139-152.

43.Herweg B, Ilercil A, Cutro R, Dewhurst R, Krishnan S, Weston M, Barold SS. Cardiac resynchronization therapy in patients with endstage inotrope-dependent class IV heart failure. Am J Cardiol. 2007;100(1):90-93.

44.Barold SS, Herweg B. Averaging detection algorithm of ICDs: Not so shocking after all! Pacing Clin Electrophysiol. 2008;31(1):17-9.

45.Barold SS, Herweg B. Pacing in heart failure: how many leads and where? Heart. 2008;94(1):10-12.

46.Herweg B, Barold SS. When is it too late for cardiac resynchronization therapy? Pacing Clin Electrophysiol. 2008;31:525-528.

47.Herweg B, Ilercil A, Madramootoo C, Ali R, Barold SS. AV junctional ablation allowing more effective delivery of cardiac resynchronization therapy in patients with intra- and inter-atrial conduction delay. Pacing Clin Electrophysiol. 2008 Jun;31(6):685-90.

48.Barold SS, Ilercil A, Herweg B. Echocardiographic optimization of the atrio-ventricular and interventricular intervals during cardiac resynchronization. Europace 2008 (in press).

49.Barold SS, Herweg B. Making sense of the new ICD algorithms for the treatment of fast ventricular tachycardia. Pacing Clin Electrophysiol. 2008 (in press).

50.Herweg B, Ali R, Khan N, Ilercil A, Barold SS. Esophageal contour changes during cryoablation of atrial fibrillation. Pacing Clin Electrophysiol. 2008 (in press).

Book Chapters

1.Rosen MR, Plotnikov A, Gainullin R, Chandra P, Herweg B, Danillo P. Changes in heart rate and activation pathway and their role in modifying cardiac repolarization. In Singh BN, Vanhoutte PM, ed. Selective and specific If inhibition in cardiovascular disease. London: Lippincott Williams & Wilkins, 2003:37-44.

2.Barold SS, Herweg B, Curtis AB. Loss of resynchronization by biventricular pacemakers: Mechanisms, diagnosis and therapy. Raviele A (Ed), Cardiac Arrhythmia 2005, Raviele A (Ed), Milan, Italy, Springer Italia 2006:531-545.

3.Curtis AB, Barold SS, Herweg B. The importance of minimizing right ventricular pacing in patients with sick sinus syndrome. Why and how? Cardiac Arrhythmias 2005, Raviele A (Ed), Milan, Italy, Springer Italia 2006: 557-568.

4.Barold SS, Herweg B. Acquired atrioventricular block. In: Kusumoto FM, Goldschlager NF (Eds), Cardiac Pacing for the Clinician (Second Edition). New York: Springer, 2008;407-427.

5.Kahn NG, Curtis AB, Herweg B, Barold SS. Do the official guidelines for CRT need to be changed? In: Ritter P, Barold SS (Eds), Cardiac Resynchronization. Technologic and Clinical Aspects. New York, NY, Springer 2008:3-15.

6.Barold SS, Herweg B. Update of cardiac resynchronization trials. In: Ritter P, Barold SS (Eds), Cardiac Resynchronization. Technologic and Clinical Aspects. New York, NY, Springer 2008:95-104.

7.Herweg B, Ilercil A, Madramootoo C, Khan NG, Barold SS. Significance of latency during left ventricular pacing for cardiac resynchronization therapy. In: Ritter P, Barold SS (Eds), Cardiac Resynchronization. Technologic and Clinical Aspects. New York, NY, Springer 2008:225-235.

8.Barold SS, Ilercil A, Herweg B. Programmability of the interventricular (V-V) interval during cardiac resynchronization therapy. In: Ritter P, Barold SS (Eds), Cardiac Resynchronization. Technologic and Clinical Aspects. New York, NY, Springer 2008:237-251.

9.Barold SS, Giudici M, Herweg B. The standard electrocardiogram during cardiac resynchronization. In: Ritter P, Barold SS (Eds), Cardiac Resynchronization. Technologic and Clinical Aspects. New York, NY, Springer 2008:425-456.

10.Barold SS, Herweg B. Cardiac arrhythmias after cardiac resynchronization. In: Barold SS, Ritter P (Eds), Devices for Cardiac Resynchronization. Technologic and Clinical Aspects, New York, NY, Springer 2008:457-473.

11.Barold SS, Ilercil A, Garrigue S, Herweg B. Optimization of the interventricular (V-V) interval during cardiac resynchronization therapy. In: Cardiac Resynchronization Therapy, St John Sutton M, Bax JJ, Jessup M, Brugada J, Schalij MJ (Eds), London, England, Informa Healthcare 2007:165-176.

12.Barold SS, Ilercil A, Garrigue S, Herweg B. Optimization of the atrio-ventricular interval during cardiac resynchronization therapy. In: Cardiac Resynchronization Therapy, St John Sutton M, Bax JJ, Jessup M, Brugada J, Schalij MJ (Eds), London, England, Informa Healthcare 2007:145-163.

13.Barold SS, Giudici MC, Herweg B. Importance of the surface electrocardiogram for the assessment of cardiac resynchronization. In: Yu CM, Hayes D, Auricchio A (Eds), Cardiac Resynchronization Therapy, 2nd edition, Blackwell-Wiley (in press).

14.Herweg B, Ilercil A, Barold SS. Programming the CRT device. In: Pacing to Support the Failing Heart, Ellenbogen KA, Auricchio A (Eds), Blackwell-Wiley2008:120-146.

Non-Peer Reviewed Reviews, Monographs

1.Herweg B: Localization and incidence of vascular occlusive disease in the aortofemoral system: significance of age, gender and risk factors. Doctoral Dissertation, University Essen, May 1991.

2.Herweg B, Dalal P, Nagy B, Schweitzer P: Power spectral analysis of heart period variability of preceding sinus rhythm before initiation of paroxysmal atrial fibrillation. Am Coll Cardiol Journal Review 1999; 8(3):16.

3.Herweg B, Steinberg J: Oral Antiarrhythmic drugs used for arrhythmia prevention. Cardiac Electrophysiology Review 2000; 4:255-261.

4.Barold SS, Herweg B, Ilercil A. Intermittent loss of atrial capture occurring every 3 beats in an asymptomatic patient with sick sinus syndrome and a 6 year-old AAI pacemaker. What is the mechanism? Turk Aritmi Pacemaker ve Elektrofizyoloji Dergisi. 2004;2:147-148.

5.Barold SS, Souder R, Ilercil A, Herweg B. Sensing of the R-wave by the atrial channel of a dual chamber pacemaker ahead of the ventricular channel. A cause of ventriculoatrial crosstalk. Turk Aritmi Pacemaker ve Elektrofizyoloji Dergisi.2004;2:226.

6.Barold SS, Sayad D, Gallardo I, Herweg B. Varying Duration of Ventricular Paced Cycles During Automatic Mode Switching of a DDDR Pacemaker. Stimucoeur 2005,33:8-10.

7.Barold SS, Souder R, Ilercil A, Herweg B. Dominant R Wave of Paced QRS Complexes in Lead V1. What is the Mechanism? Turk Aritmi Pacemaker ve Elektrofizyoloji Dergisi. 2005;3:75-80.

8.Barold SS, Souder R, Ilercil A, Herweg B. Electrocardiographic diagnosis of  myocardial infarction and ischemia during ventricular pacing. Turk Aritmi Pacemaker ve Elektrofizyoloji Dergisi. 2005;3:7-16.

9.Barold SS, Souder R, Ilercil A, Herweg B. Pacemaker repetitive nonreentrant ventriculoatrial synchrony and its relationship to endless loop tachycardia. Turk Aritmi Pacemaker ve Elektrofizyoloji Dergisi 2005;3:144-151.

10.Glaser V, Glatter K, Herweg B, Jaffe C. Atrial fibrillation treatment focus shifts from rhythm to rate control. Patients Care 2006;40(1):58-66.

11.Barold SS, Herweg B. The spectrum of aquired atrioventricular block in clinical practice. Hospital Chronicles 2006;1:1-11.

12.Barold SS, Stroobandt RX, Leonelli F, Herweg B. Electrical desynchronization in biventricular pacemakers. Turkish Journal of Arrhythmia, Pacing & Electrophysiology 2006;4:258-65.

13.Barold SS, Souder R, Ilercil A, Herweg B. Biventriküler ICD'de e?ik testi s?ras?nda QRS morfolojisi de?i?imi. Mekanizma nedir? Changes in QRS morphology during pacing threshold testing of a biventricular ICD. What is the Mechanism? Türk Aritmi Pacemaker ve Elektrofizyoloji Dergisi 2007;4(2):173–176.

14.Barold SS, Souder R, Ilercil A, Herweg B. Hyperkalemia and Cardiac Pacing. Türk Aritmi Pacemaker ve Elektrofizyoloji Dergisi 2007;4(2):83–88.

15.Herweg B. Hybrid cryo-radiofrequency ablation approach for atrial fibrillation. EP Lab Digest. 2008;January:20.

16.Barold SS, Herweg B. ICD lead malfunction. Turkish Journal of Arrhythmia, Pacing & Electrophysiology 2008; (In press).

Multicenter Trials

1. The DAVID Trial Investigators. Dual chamber pacing of ventricular backup pacing in patients with an implantable defibrillator. The dual chamber and VVI implantable defibrillator (DAVID) trial. JAMA 2002;288:3115-3123.

2. Doshi RN, Daoud EG, Fellows C, Turk K, Duran A, Hamdan MH, Pires LA. Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (The PAVE study). J Cardiovasc Electrophysiol 2005;16:1160-1165.

3. Benditt DG. The Ad Hoc Syncope Consortium. The ACCF/AHA scientific statement on syncope. A document in need of thoughtful revision. Clin Auton Res 2006 (in press)

Abstracts (peer reviewed)

1.Dalal P, Herweg B, Schweitzer P. Autonomic nervous system activity before onset of paroxysmal atrial fibrillation by power spectral analysis of heart rate. J Am Coll Cardiol 1994;23:457A. (presented at ACC, 43rd Annual Scientific Session, 1994)

2.Herweg B, Martinez M, Ferrick KJ, Fisher JD. T-wave memory after changes in activation pattern following radiofrequency ablation of accessory pathways. Eur J Cardiac Pacing Electrophysiol 1996;6(1):76. (presented at Cardiostim, 1996)

3.Herweg B, Martinez M, Ferrick KJ, Fisher JD. Atrial fibrillation in pre-excitation syndromes: The pivotal role of a functioning accessory pathway. Eur J Cardiac Pacing Electrophysiol 1996;6(1):49. (presented at Cardiostim, 1996)

4.Herweg B, Toosi B, Martinez M, Kim SG, Ferrick KJ, Fisher JD. Autonomic modulation of accessory pathway function in the Wolf-Parkinson-White syndrome: Sympathetic predominance in patients with atrial fibrillation. Pacing Clin Electrophysiol 1997;20:1176. (presented at NASPE, 1997)

5.Herweg B, Weiner S, Ilercil A, Gross JN, Kim SG, Ferrick KJ, Fisher JD. T wave memory is a surface electrocardiografic indicator of orthodromic reciprocating tachycardia in patients with narrow complex tachycardia. Pacing Clin Electrophysiol 1998;21:926. (presented at NASPE, 1998)

6.Herweg B, Toosi B, Ilercil A, Kim SG, Gross JN, Fisher JD, Ferrick KJ. Autonomic modulation of accessory pathway function and associated arrhthmias in the Wolff-Parkinson-White syndrome. Arch Mal Coeur 1998;91(III):337. (presented at Cardiostim 1998)

7.Herweg B, Weiner S, Ilercil A, Gross JN, Kim SG, Ferrick KJ, Fisher JD. T wave memory indicates atrio-ventricular reentry in ongoing narrow complex tachycardia. Arch Mal Coeur 1998;91(III):191. (presented at Cardiostim 1998)

8.Herweg B, Chang F, Danilo P, Rosen MR. Cardiac memory is demonstrable in atrium. Circulation 1999;100:I-159. (presented at the AHA, 72nd Scientific Session, November 1999)

9.Chang F, Herweg B, Danilo P, Rosen MR. Effects of rate and activation sequence on Ta wave memory. Circulation 1999;100:I-50. (presented at the AHA, 72nd Scientific Session, November 1999)

10.Herweg B, Rill V, Kaddaha R, Cohen AJ, Steinberg JS. Atrial flutter is associated with activation of the endogenous coagulation system. Circulation 2000;102:II-618. (presented at the AHA, 73nd Scientific Session, November 2000)

11.Chandra P, Herweg B, Rosen TS, Danilo P, Rosen MR. Altered activation induces atrial memory and atrial tachyarrhythmias in canine heart. Circulation 2000;102:II-322. (presented at the AHA, 73nd Scientific Session, November 2000)

12.Herweg B, Ziaie Matin M, Kaddaha RM, Ehlert FA, Vloka ME, Cohen AJ, Steinberg JS. Elevated levels of factor VIII:C in patients with atrial flutter and decreased left ventricular function. J Am Coll Cardiol 2001;37(2):104A. (presented at ACC, 50th Annual Scientific Session, 2001)

13.Herweg B, Chandra P, Anyukhovsky EP, Sosunov EA, Danilo P, Rosen MR. The physiologic right to left atrial gradient of action potential duration and refractoriness decreases with pacing induced atrial fibrillation. J Am Coll Cardiol 2001;37(2):111A. (presented at ACC, 50th Annual Scientific Session, 2001)

14.Chandra P, Rosen TS, Herweg B, Plotnikov AN, Danilo P Jr., Rosen MR. Evolution of the atrial gradient may predict a propensity to atrial tachyarrhythmias. Circulation 2001;104:II-109. (presented at the AHA, 74nd Scientific Session, November 2001)

15.Herweg B, Chaudhry FA, Singh BK, Cohen AJ, Steinberg JS. Spontaneous echocontrast and decreased left atrial appendage emptying velocity in patients with isthmus dependent atrial flutter are associated with increased activity of thrombin-antithrombin III complex and prothrobin fragments 1+2. Circulation 2001;104:II-716. (presented at the AHA, 74nd Scientific Session, November 2001)

16.Rozenshtein A, Bauman-Fishkin O, Polosajian L, Herweg B, Sichrovsky TC, Hefer D, Steinberg JS, Boxt L. Angiogram of the pulmonary veins in patients with paroxysmal atrial fibrillation. Am J Roentgen 2002;178(3):23. (presented to American Roentgen Ray Society, 2002)

17.Polosajian L, Herweg B, Sichrovsky TC, Hefer D, Rozenshtein A, Steinberg JS. Pulmonary vein diameter is increased in patients with paroxysmal atrial fibrillation compared to age matched controls. J Am Coll Cardiol 2002;39(5):116A. (presented at 51th Annual Scientific Session, 2002)

18.Chandra P, Rosen T, Herweg B, Plotnikov AN, Danilo P, Rosen MR. Atrial memory: Association with atrial fibrillation. Pacing Clin Electrophysiol 2002;25(4):576. (presented at NASPE 2002)

19.Petre L, Herweg B, Steinberg JS, Chaudhry F. Cardioversion in patients with left ventricular thrombus is not associated with increased thromboembolic risk. Circulation Online 2002;P249 (#100292). (presented at the AHA stroke session, October 2002)

20.Kowalski M, Steinberg JS, Arshad A, Kukar A, Suma V, Vloka ME, Ehlert FA, Herweg B, Donnelly JE, Philip J, Reed G, Rozanski A. A new pattern of cardiac events emerges following the world trade center attack. Circulation 2002;106(19):II-755. (presented at the AHA, 75nd Scientific Session, November 2002)

21.Herweg B, Sichrovsky TC, Polosajian L, Maleki K, Hefer D, Steinberg JS. High prevalence of a common pulmonary vein orifice: Implication on ablation technique. Circulation 2002;106(19):II-500. (oral presentation at the AHA, 75nd Scientific Session, November 2002)

22.Arshad A, Kowalski M, Kukar A, Suma V, Vloka ME, Ehlert FA, Herweg B, Donnelly JE, Philip J, Reed G, Rozanski A, Steinberg JS. Frequency of implantable cardioverter-defibrillator discharges in New York following the World Trade Center attack. J Am Coll Cardiol 2003;41(6):86A. (presented at 51th Annual Scientific Session, 2003)

23.Hart DT, Petre L, Ashad R, Herweg B, Steinberg J. Assessment of ventricular capture in patients with cardiac resynchronization devices: A simple surface electrocardiographic algorithm. Pacing Clin Electrophysiol 2003;26(4):1083. (presented at NASPE, 2003)

24.Chandra P, Rosen TS, Herweg B, Plotnikov AN, Danilo P, Rosen MR. Atrial Gradient and Effective Refractory Period as Predictors of Atrial Fibrillation in a Canine Model. Heart Rhythm 2004;1(1S):S61. (presented at NASPE, 2004)

25.Herweg B, Sichrovsky TC, Petre L, Polosajian L, Steinberg JS. Relationship of ostial pulmonary vein diameter to hypertension and left ventricular hypertrophy. J Am Coll Cardiol 2004;43(5):118A. (presented at ACC, 52th Annual Scientific Session, 2004)

26.Herweg B, Ilercil A, Dewhurst R, Singh A, Cutro R, Barold SS, Curtis AB, Weston M. Cardiac Resynchronization Therapy in Patients with Endstage Inotrope-Dependent Class IV Heart Failure. Europace 2006;Supplement 1(8);211/1. (presented at Cardiostim 2006)

27.Herweg B, Ali R. Madramootoo C, Ilercil A, Barold SS. Left ventricular latency may require interventricular interval adjustments to assure response to cardiac resynchronization. Heart Rhythm 2008;5(5):S238. (presented at Heart Rhythm 29th Annual Scientific Session, 2008)

28.Herweg B, Ali R. Madramootoo C, Ilercil A, Barold SS. Correlation of left ventricular latency with optimized V-V intervals during cardiac resynchronization. Europace 2008;10 Supplement 1;i164,226L/5. (presented at Cardiostim 2008).

29.Ali R, Cutro R, Madramootoo C, Barold SS, Ilercil A, Herweg B. Echocardiographic biventricular pacemaker optimization reveals longer, more physiologic atrio-ventricular intervals in patients with complete heart block. (Presented at the Florida American College of Cardiology 2008).

30.Ali R, Khan N, Ilercil A, Barold SS, Herweg B. Esophageal contour changes during cryo-ablation of atrial fibrillation. (Presented at the Young Investgator Award Competition at the Scientific Sessions of the Florida American College of Cardiology 2008).

Manuscripts in Preparation/Submitted/in Review

1.Herweg B, Ziaie-Matin M, Chaudhry FA, Singh BK, Drejka ML, Cohen AJ, Steinberg JS. Activation of the endogenous coagulation system in patients with atrial flutter: Relationship to echocardiographic markers of thrombo-embolic risk. (submitted for publicatition)